Neurol. praxi. 2018;19(2):96-99 | DOI: 10.36290/neu.2018.084

Autoimmune disorders of the central nervous system in childhood: updates and terminology

MUDr. Zuzana Libá, Ph.D.
Klinika dětské neurologie, 2. LF UK a FN Motol, Praha

Autoimmune disorders affecting central nervous system are potentially treatable. They are rare in childhood and a clinical courseis often serious. The classification and diagnostic criteria are developing as well as therapeutic approaches. The aim is to determinea diagnosis of autoimmune condition and to initiate an accurate therapy as soon as possible. This review is focused on updatesof the most common clinical diagnoses and the terminology in this area.

Keywords: acquired demyelinating syndrome, autoimmune encephalitis, children, myelin-oligodendrocyte glycoprotein, aquaporin 4

Published: May 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Libá Z. Autoimmune disorders of the central nervous system in childhood: updates and terminology. Neurol. praxi. 2018;19(2):96-99. doi: 10.36290/neu.2018.084.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol 2012; 27(11): 1460-1469. Go to original source... Go to PubMed...
    2. Hacohen Y, Mankad K, Chong WK, Barkhof F, Vincent A, Lim M, Wassmer E, Ciccarelli O, Hemingway C. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology 2017; 89(3): 269-278. Go to original source... Go to PubMed...
    3. Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, Brantner-Inthaler S, Diepold K, Eisenkölbl A, Gotwald T, Kuchukhidze G, Gruber-Sedlmayr U, Häusler M, Höftberger R, Karenfort M, Klein A, Koch J, Kraus V, Lechner C, Leiz S, Leypoldt F, Mader S, Marquard K, Poggenburg I, Pohl D, Pritsch M, Raucherzauner M, Schimmel M, Thiels C, Tibussek D, Vieker S, Zeches C, Berger T, Reindl M, Rostásy K; BIOMARKER Study Group. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology 2017; 89(9): 900-908. Go to original source... Go to PubMed...
    4. Hintzen RQ, Dale RC, Neuteboom RF, Mar S, Banwell B. Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis. Neurology 2016; 87(9 Suppl. 2): S67-73. Go to original source... Go to PubMed...
    5. Ghezzi A, Amato MP, Makhani N, Schreiner T, Gärtner J, Tenembaum S. Pediatric multiple sclerosis: Conventional first-line treatment and general management. Neurology 2016, 87(9 Suppl 2): S97-S102. Review. Erratum in: Neurology. 2016; 87(19): 2068. Go to original source... Go to PubMed...
    6. Chitnis T, Ghezzi A, Bajer-Kornek B, Boyko A, Giovannoni G, Pohl D. Pediatric multiple sclerosis: escalation and emerging treatments. Neurology 2016; 87(9 Suppl. 2): S103-109. Go to original source... Go to PubMed...
    7. Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology 2016; 87(9 Suppl. 2): S38-45. Go to original source... Go to PubMed...
    8. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology 2011; 69(2): 292-302. Go to original source... Go to PubMed...
    9. Rostasy K, Bajer-Kornek B, Venkateswaran S, Hemingway C, Tardieu M. Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders. Neurology 2016; 87: S28-S37. Go to original source... Go to PubMed...
    10. Tardieu M, Banwell B, Wolinsky JS, Pohl D, Krupp LB. Consensus definitions for pediatric MS and other demyelinating disorders in childhood. Neurology 2016; 87: S8-S11. Go to original source... Go to PubMed...
    11. Tenembaum S, Chitnis S, Nakashima I, Collongues N, McKeon A, Levy M, Rostasy K. Neuromyelitis optica spectrum disorders in children and adolescents. Neurology 2016; 87: S59-S66. Go to original source... Go to PubMed...
    12. Thompson AJ, Banwell BL, Barkhof F. Diagnosis of multiple sclerosis: 2017 revision of the McDonald criteria. Lancet Neurol 2017; pii: S1474-4422(17)30470-2.
    13. Waldman A, Ness J, Pohl D, Simone IL, Anlar B, Amato MP, Ghezzi A. Pediatric multiple sclerosis: clinical features and outcome. Neurology 2016; 87(9 Suppl. 2): S74-81. Go to original source... Go to PubMed...
    14. Winderchuk DM, Banwell B, Bennett. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85(2): 177-189. Go to original source... Go to PubMed...
    15. Wright S, Hacohen Y, Jacobson L, Agrawal S, Gupta R, Philip S, Smith M, Lim M, Wassmer E, Vincent A. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child. 2015; 100(6): 521-526. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.